"Bacterial Toxins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Toxic substances formed in or elaborated by bacteria; they are usually proteins with high molecular weight and antigenicity; some are used as antibiotics and some to skin test for the presence of or susceptibility to certain diseases.
| Descriptor ID |
D001427
|
| MeSH Number(s) |
D23.946.123
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Bacterial Toxins".
Below are MeSH descriptors whose meaning is more specific than "Bacterial Toxins".
This graph shows the total number of publications written about "Bacterial Toxins" by people in this website by year, and whether "Bacterial Toxins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1995 | 3 | 3 | 6 |
| 1996 | 4 | 0 | 4 |
| 1997 | 2 | 3 | 5 |
| 1998 | 2 | 2 | 4 |
| 1999 | 5 | 2 | 7 |
| 2000 | 4 | 0 | 4 |
| 2001 | 3 | 2 | 5 |
| 2002 | 4 | 2 | 6 |
| 2003 | 3 | 0 | 3 |
| 2004 | 2 | 2 | 4 |
| 2005 | 2 | 2 | 4 |
| 2006 | 6 | 5 | 11 |
| 2007 | 8 | 2 | 10 |
| 2008 | 8 | 1 | 9 |
| 2009 | 4 | 3 | 7 |
| 2010 | 3 | 3 | 6 |
| 2011 | 4 | 2 | 6 |
| 2012 | 2 | 1 | 3 |
| 2013 | 4 | 0 | 4 |
| 2014 | 3 | 1 | 4 |
| 2015 | 2 | 1 | 3 |
| 2016 | 3 | 1 | 4 |
| 2017 | 2 | 0 | 2 |
| 2018 | 3 | 4 | 7 |
| 2019 | 1 | 1 | 2 |
| 2020 | 5 | 1 | 6 |
| 2021 | 1 | 3 | 4 |
| 2022 | 4 | 0 | 4 |
| 2023 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Bacterial Toxins" by people in Profiles.
-
Stool Interleukin-1? Differentiates Clostridioides difficile Infection (CDI) From Asymptomatic Carriage and Non-CDI Diarrhea. Clin Infect Dis. 2023 02 08; 76(3):e1467-e1475.
-
Baseline stool toxin concentration is associated with risk of recurrence in children with Clostridioides difficile infection. Infect Control Hosp Epidemiol. 2023 09; 44(9):1403-1409.
-
Higher In Vivo Fecal Concentrations of Clostridioides difficile Toxins A and B in Patients With North American Pulsed-Field Gel Electrophoresis Type 1/Ribotype 027 Strain Infection. Clin Infect Dis. 2022 11 30; 75(11):2019-2022.
-
Stool Toxin Concentration Does Not Distinguish Clostridioides difficile Infection from Colonization in Children Less Than 3 Years of Age. J Pediatric Infect Dis Soc. 2022 Oct 25; 11(10):454-458.
-
Ultrasensitive and Quantitative Toxin Measurement Correlates With Baseline Severity, Severe Outcomes, and Recurrence Among Hospitalized Patients With Clostridioides difficile Infection. Clin Infect Dis. 2022 07 06; 74(12):2142-2149.
-
Depletion of the apical endosome in response to viruses and bacterial toxins provides cell-autonomous host defense at mucosal surfaces. Cell Host Microbe. 2022 02 09; 30(2):216-231.e5.
-
Group B Streptococcus CAMP Factor Does Not Contribute to Interactions with the Vaginal Epithelium and Is Dispensable for Vaginal Colonization in Mice. Microbiol Spectr. 2021 12 22; 9(3):e0105821.
-
Ontogeny and function of the circadian clock in intestinal organoids. EMBO J. 2022 12 17; 41(2):e106973.
-
Comparative clinical outcomes evaluation of hospitalized patients infected with Clostridioides difficile ribotype 106 vs. other toxigenic strains. Anaerobe. 2021 Dec; 72:102440.
-
Clostridioides difficile Infection in Cancer and Immunocompromised Patients: Relevance of a Two-step Diagnostic Algorithm and Infecting Ribotypes on Clinical Outcomes. Clin Infect Dis. 2021 05 18; 72(10):e460-e465.